BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19289118)

  • 1. A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.
    Lombardi MS; Jaspers L; Spronkmans C; Gellera C; Taroni F; Di Maria E; Donato SD; Kaemmerer WF
    Exp Neurol; 2009 Jun; 217(2):312-9. PubMed ID: 19289118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts.
    van Bilsen PH; Jaspers L; Lombardi MS; Odekerken JC; Burright EN; Kaemmerer WF
    Hum Gene Ther; 2008 Jul; 19(7):710-9. PubMed ID: 18549309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA.
    Gonzalez-Alegre P; Miller VM; Davidson BL; Paulson HL
    Ann Neurol; 2003 Jun; 53(6):781-7. PubMed ID: 12783425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.
    Pfister EL; Kennington L; Straubhaar J; Wagh S; Liu W; DiFiglia M; Landwehrmeyer B; Vonsattel JP; Zamore PD; Aronin N
    Curr Biol; 2009 May; 19(9):774-8. PubMed ID: 19361997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells.
    Miller JRC; Pfister EL; Liu W; Andre R; Träger U; Kennington LA; Lo K; Dijkstra S; Macdonald D; Ostroff G; Aronin N; Tabrizi SJ
    Sci Rep; 2017 Apr; 7():46740. PubMed ID: 28436437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific silencing by RNA interference.
    Hohjoh H
    Methods Mol Biol; 2010; 623():67-79. PubMed ID: 20217544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HD phenocopies--possible role of Saitohin gene.
    Janković N; Kecmanović M; Dimitrijević R; Keckarević Marković M; Dobricić V; Keckarević D; Savić Pavicević D; Romac S
    Int J Neurosci; 2008 Mar; 118(3):391-7. PubMed ID: 18300012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
    Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.
    Kay C; Collins JA; Skotte NH; Southwell AL; Warby SC; Caron NS; Doty CN; Nguyen B; Griguoli A; Ross CJ; Squitieri F; Hayden MR
    Mol Ther; 2015 Nov; 23(11):1759-1771. PubMed ID: 26201449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells.
    Drouet V; Ruiz M; Zala D; Feyeux M; Auregan G; Cambon K; Troquier L; Carpentier J; Aubert S; Merienne N; Bourgois-Rocha F; Hassig R; Rey M; Dufour N; Saudou F; Perrier AL; Hantraye P; Déglon N
    PLoS One; 2014; 9(6):e99341. PubMed ID: 24926995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
    Kay C; Collins JA; Caron NS; Agostinho LA; Findlay-Black H; Casal L; Sumathipala D; Dissanayake VHW; Cornejo-Olivas M; Baine F; Krause A; Greenberg JL; Paiva CLA; Squitieri F; Hayden MR
    Am J Hum Genet; 2019 Dec; 105(6):1112-1125. PubMed ID: 31708117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic background of Huntington disease in Croatia: Molecular analysis of CAG, CCG, and Delta2642 (E2642del) polymorphisms.
    Hećimović S; Klepac N; Vlasić J; Vojta A; Janko D; Skarpa-Prpić I; Canki-Klain N; Marković D; Bozikov J; Relja M; Pavelić K
    Hum Mutat; 2002 Sep; 20(3):233. PubMed ID: 12204002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype.
    Mancuso M; Kiferle L; Petrozzi L; Nesti C; Rocchi A; Ceravolo R; Orsucci D; Maluccio MR; Bonuccelli U; Filosto M; Siciliano G; Murri L
    Neurosci Lett; 2008 Oct; 444(1):83-6. PubMed ID: 18706972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing.
    McCusker E; Richards F; Sillence D; Wilson M; Trent RJ
    J Clin Neurosci; 2000 Jan; 7(1):38-41. PubMed ID: 10847649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi of COL1A1 in mesenchymal progenitor cells.
    Millington-Ward S; McMahon HP; Allen D; Tuohy G; Kiang AS; Palfi A; Kenna PF; Humphries P; Farrar GJ
    Eur J Hum Genet; 2004 Oct; 12(10):864-6. PubMed ID: 15241481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating PVALB as a candidate gene for SLC12A3-negative cases of Gitelman's syndrome.
    Riveira-Munoz E; Devuyst O; Belge H; Jeck N; Strompf L; Vargas-Poussou R; Jeunemaître X; Blanchard A; Knoers NV; Konrad M; Dahan K
    Nephrol Dial Transplant; 2008 Oct; 23(10):3120-5. PubMed ID: 18469313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-Specific Knockdown of Mutant Huntingtin Protein via Editing at Coding Region Single Nucleotide Polymorphism Heterozygosities.
    Oikemus SR; Pfister EL; Sapp E; Chase KO; Kennington LA; Hudgens E; Miller R; Zhu LJ; Chaudhary A; Mick EO; Sena-Esteves M; Wolfe SA; DiFiglia M; Aronin N; Brodsky MH
    Hum Gene Ther; 2022 Jan; 33(1-2):25-36. PubMed ID: 34376056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.